Shanghai Rainminda Pharmaceutical Co., Ltd. was established in 2022 and is a wholly-owned subsidiary of Binhui Biopharma Co., Ltd It focuses on the field of cell and gene therapy, providing personalized customization, testing, and consulting services for viruses, nucleic acids, proteins, and cells. At the same time, it provides spot products such as cells, viruses, genes, reagents, test kits, instruments and equipment, helping pharmaceutical companies, universities, and research institutions in accelerating achievements transformation.

The company has multiple research and development production bases in Shanghai, Wuhan, and Shaoxing, with a total construction area 7000 square meters, it has production processes recognized by NMPA and FDA, and the integration of production and research can fully meet the needs of clinical research and industrialization. Establish a clean pilot plant that meets GMP standards, and multiple production lines can be used simultaneously; Equipped with high connotation cell imaging systems, bioreactors, small animal live imaging devices, AKTA chromatography purification systems, flow cytometers, real-time fluorescence quantitative PCR machines, water production and filling facilities and equipment, it can meet the needs of product development and clinical trial drug production.